Living with a chronic illness that requires a lifelong commitment to a strict gluten-free diet can be difficult for anyone. For children and teens, the emotional and psychological impact associated…
Continue ReadingDigestive Disease Week® (DDW) is the largest international gathering of physicians, researchers, and academics in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. Held on May 16-19 in Washington…
Continue Reading“You almost have to have a PhD in Food Science these days just to read a nutrition label,” Shelley Case, BSc, RD, CDF Medical Advisory Board Member, joked while addressing…
Continue ReadingOn May 11, 2015, CDF CEO Marilyn G. Geller was proud to represent the celiac community at the public meeting of the U.S. Food and Drug Administration Functional GI Patient-Focused…
Continue ReadingLife-Changing Opportunity for Individuals with Celiac Disease and other Gluten-Related Disorders in Pasadena, CA May 2-3, 2015 Celiac Disease Foundation (CDF) is pleased to announce that over 2,700 people –…
Continue ReadingIn the United States, an estimated three million Americans suffer from celiac disease. Due to lack of information about celiac disease manifestation, roughly 83% of Americans who experience symptoms go…
Continue ReadingThe CDF Gluten-Free EXPO was the largest yet! Nearly 3000 attendees sampled the best Los Angeles has to offer on May 2nd and 3rd. Life in LA sent their reporter to check out the exciting
Continue ReadingOn behalf of our patient community, CDF has either directly invested or fought to secure investments in diagnostics, research, and treatment for celiac disease. We have always known that this was a serious disease with broad and often devastating impacts if left undiagnosed and/or untreated. Our 25 years of hard work continues to yield returns. This is from a NY Times article published on April 29, 2015, "Pharmaceutical companies are racing to develop the first drugs for celiac disease, which researchers say is much more common than previously thought."
Continue ReadingOn May 11, 2015, the Food and Drug Administration (FDA) will conduct a public meeting on Functional GI Disorders Patient-Focused Drug Development. Celiac Disease Foundation was requested by the FDA to provide commentary about the impact of celiac disease on patients’ daily lives, the types of treatment benefit that matter most to patients, and patients’ perspectives on the adequacy of the available therapies.
Continue ReadingConsidering the rising number of cases of celiac disease, and its extremely detrimental effects on childhood development, leading to malabsorption and failure to thrive, it is becoming more necessary to find a means to properly diagnose young children.
Continue ReadingDear Celiac Disease Foundation Community, For more than three decades, the Celiac Disease Foundation has been dedicated to improving the lives of those affected by celiac disease through research, advocacy, and education. What began as a grassroots effort has grown into a global organization, leading the charge in accelerating diagnosis,...